Kristal Robert Eugene 4
4 · BioRestorative Therapies, Inc. · Filed Feb 15, 2024
Insider Transaction Report
Form 4
Kristal Robert Eugene
Chief Financial Officer
Transactions
- Award
Stock Option
2024-02-13+263,158→ 263,158 totalExercise: $1.45Exp: 2034-02-13→ Common Stock (263,158 underlying)
Holdings
- 7,994
Common Stock
- 10,490
Stock Option
Exercise: $5.08Exp: 2031-11-04→ Common Stock (10,490 underlying) - 88,968
Stock Option
Exercise: $2.91Exp: 2033-02-17→ Common Stock (88,968 underlying)
Footnotes (3)
- [F1]The option is currently exercisable.
- [F2]The option vests and becomes exercisable to the extent of 44,484 shares on February 17, 2023 with the remaining 44,484 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested.
- [F3]The option vests and becomes exercisable to the extent of 131,579 shares on February 13, 2024 with the remaining 131,579 shares vesting in eight nearly-equal quarterly installments beginning on February 13, 2025 and continuing every three months thereafter until fully vested.